The Efficacy of Paraprobiotic, Probiotic, and Mineral Supplementation on the Eradication Rate of Helicobacter pylori in Patients with Dyspepsia: A Randomized Clinical Trial
Table 1
Demographic and clinical characteristics of the patients in both treatment groups.
Group A (without Pyloshot)
Group B (with Pyloshot)
value
Male/female,
17/18
16/18
0.9
Age, mean (SD), years
44.05 (13.66)
42.49 (14.17)
0.64
Smokers, (%)
6 (17.1%)
6 (17.6%)
0.95
History of NSAID consumption, (%)
8 (22.8%)
7 (20.5%)
0.81
History of H. pylori treatment more than one year before recent presentation, (%)
